Annandale Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.39M | Sell |
29,060
-80
| -0.3% | -$14.8K | 0.41% | 29 |
|
|
2025
Q1 | $6.11M | Hold |
29,140
| – | – | 0.39% | 26 |
|
|
2024
Q4 | $5.18M | Buy |
29,140
+34
| +0.1% | +$6.04K | 0.82% | 28 |
|
|
2024
Q3 | $5.75M | Hold |
29,106
| – | – | 0.81% | 25 |
|
|
2024
Q2 | $4.99M | Buy |
29,106
+25,406
| +687% | +$4.36M | 0.85% | 27 |
|
|
2024
Q1 | $674K | Hold |
3,700
| – | – | 0.12% | 77 |
|
|
2023
Q4 | $573K | Hold |
3,700
| – | – | 0.11% | 82 |
|
|
2023
Q3 | $552K | Hold |
3,700
| – | – | 0.14% | 74 |
|
|
2023
Q2 | $499K | Sell |
3,700
-65
| -2% | -$8.77K | 0.14% | 86 |
|
|
2023
Q1 | $600K | Hold |
3,765
| – | – | 0.19% | 79 |
|
|
2022
Q4 | $608K | Sell |
3,765
-377
| -9% | -$60.9K | 0.2% | 78 |
|
|
2022
Q3 | $556K | Sell |
4,142
-35
| -0.8% | -$4.7K | 0.21% | 80 |
|
|
2022
Q2 | $640K | Hold |
4,177
| – | – | 0.25% | 68 |
|
|
2022
Q1 | $677K | Hold |
4,177
| – | – | 0.27% | 66 |
|
|
2021
Q4 | $566K | Hold |
4,177
| – | – | 0.25% | 70 |
|
|
2021
Q3 | $451K | Hold |
4,177
| – | – | 0.27% | 58 |
|
|
2021
Q2 | $470K | Sell |
4,177
-2
| -0% | -$225 | 0.28% | 59 |
|
|
2021
Q1 | $452K | Sell |
4,179
-54
| -1% | -$5.84K | 0.32% | 43 |
|
|
2020
Q4 | $454K | Buy |
+4,233
| New | +$454K | 0.38% | 33 |
|